Susan B. Stewart - 11 Apr 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Regulatory Officer
Signature
/s/ John Canepa, as Attorney-In-Fact for Susan B. Stewart
Issuer symbol
CADL
Transactions as of
11 Apr 2022
Net transactions value
$0
Form type
4
Filing time
12 Apr 2022, 17:15:10 UTC
Previous filing
26 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 11 Apr 2022 Common Stock 20,000 $5.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on May 11, 2022, subject to the Reporting Person's continued service on each such vesting date.